SWOG clinical trial number
SWOG-8807

An Investigation of the Relationship Between an Integrated, System Education Approach and Breast Self Exam (BSE) Compliance

Closed
Phase
Accrual
77%
Published
Abbreviated Title
An Investigation of the Relationship Between an Integrated, System Education Approach and Breast Self Exam (BSE) Compliance
Activated
05/15/1989
Closed
12/01/1993

Research committees

Breast Cancer

Publication Information Expand/Collapse

2014

Enhancing nurse contributions to SWOG clinical trials

L Hansen;C Moinpour;R Ermete Seminars in Nursing Oncology 30(1):26-31;

PMid: PMID24559777 | PMC number: PMC3961058

2000

Behavioral science research in the cooperative group setting: the Southwest Oncology Group Experience

CC Gotay;CM Moinpour;S Moody-Thomas;ER Gritz;KS Albain;E DeAntoni;L Hansen;PA Ganz Journal of the National Cancer Institute 92(17):1381-1387

1997

Improving breast self-examination compliance: A Southwest Oncology Group randomized trial of three interventions.

CJ Strickland;P Feigl;C Upchurch;DK King;HI Pierce;PK Grevstad;JD Bearden;M Dawson;WC Loewen;FL Meyskens Jr Preventive Medicine 26:320-332

Other Clinical Trials

SWOG Clinical Trial Number
S2206

A Randomized trial of neoadjuvant durvalumab plus chemotherapy versus chemotherapy alone for Adults with MammaPrint Ultrahigh (MP2) hormone receptor (HR) positive /Human Epidermal Growth Factor receptor (HER2) negative stage II-III breast cancer
Research Committee(s)
Breast Cancer
Symptom Control and Quality of Life
Activated
10/30/2023
Accrual
3%
Open
Phase
SWOG Clinical Trial Number
S2212

TIL Adapted Neo adjuvant Chemotherapy Optimization in Triple negative breast cancer (SCARLET)
Research Committee(s)
Breast Cancer
Activated
07/21/2023
Accrual
8%
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-BR007

A Phase III Clinical Trial Evaluating De-escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score </= 18 Breast Cancer
Research Committee(s)
Breast Cancer
Activated
06/07/2021
Open
Phase